However, the tumor entities of prostatic and breast cancer, which have mainly been shown to be associated with a reduced recurrence when regional anesthesia was applied [21,22], are characterized by a comparably slow tumor progression, frequently depending on hormone receptor status. This evidence concerns the gene NR4A1 and breast carcinoma.